chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mother reported child developed rash/hives after vaccines given. She states (R) arm was worse. She took child to Hospital and was instructed to continue BENADRYL. (2-12-15).
Pt left clinic /p recving vax.Called some minutes later describing sx of hives, warmth & redness all over body.Pt returned to clinic immediately.Received Benadryl & Epiniphrine IM.Was monitored for approx 2 hrs.
twitching of the feet and hand; body ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (twitching of the feet and hand), MYALGIA (body ache) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE TWITCHING (twitching of the feet and hand), MYALGIA (body ache) and HEADACHE (headache). At the time of the report, MUSCLE TWITCHING (twitching of the feet and hand), MYALGIA (body ache) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment drugs were reported
Narrative:  Patient was found non-responsive in the home, barely breathing by HH or PT on the morning of 8/5/22. Paramedics were called, patient passed away 8/5/22. Patient expired less than 24 hours after receiving Moderna booster. Booster was given during a primary care provider visit in the patient's home 8/4/22. Patient also had extensive health issues in addition to the recent hospital stay. Reported during home visit 8/4/22 he was getting low BP readings after dialysis - last dialysis 8/3/22. He was on home oxygen, but only reported using it if SOB or at night. In general he was feeling weak. From Hospital discharge 7/23/22 DISCHARGE DIAGNOSES: 1. Sepsis present on admit now resolved. 2. Left-sided pleural effusion, possibly parapneumonic with underlying pneumonia s/p thoracocentesis. 3. Acute hypoxemic respiratory failure 4. End-stage renal disease 5. Peripheral arterial disease 6. Debility HOSPITAL COURSE: This is a 61 y.o. male that was admitted for evaluation of nausea, vomiting and fever after undergoing hemodialysis. Initial evaluation revealing left-sided pleural effusion, requiring patient to be placed on IV antibiotics. He underwent thoracocentesis thereafter. Overall his fever has resolved and his respiratory status has improved however he still required 1 to 2 L of oxygen especially with ambulation. Suspected that his effusion may have been parapneumonic and patient did complete IV antibiotics while inpatient.
Breakthrough COVID-19 case with symptom onset 8/26/2021. Hospitalized 8/26/2021 for unknown duration. Death 9/9/2021
On 7/16/99, the pt developed clinical varicella, greater than fifty papulovesicular lesions, and a little oozing. The pt was seen by a physician. The eruptions lasted 2 weeks and cleared and then reappeared. There was no fever present. The reporter had a concern about the lot number of the vaccine. Follow-up information from a registered pharmacist reported that his son's experience was not an adverse experience.
Increase shortness of breath. Admitted into the hospital to receive IV antibiotics. Cystic Fibrosis - exacerbation.
I was about 5 to 6 weeks pregnant and I lost the baby on June 7th. About 3 weeks after the covid shoot.  I didn't even get the chance to see my Dr
Information has been received from a registered nurse (RN) concerning an infant who was vaccinated PO with a dose of Rotateq. The RN reported that the patient vomited immediately after being vaccinated. It was unknown if medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
pt recv vax & 10 days post vax pt devel a measles-like rash;
Patient reports numbness and tingling occurred in the right jaw and arm (full length of arm) starting 6/1/2022.  The symptoms went away in about 10 days.  The patient had surgery to remove an unknown carcinoma near his right ear approximately 5/17/2022 and returned to the dermatologist between 6/1/2022 and 6/11/2022 to reevaluate the surgery site.  He currently reports soreness in the right jaw when he clenches his teeth.
Rash, Extreme Irritability, Sleeping a lot since vaccine given, Lethargy, Very fussy when you hold him and touch him.
That evening if the dose I developed chills, fatigue, and weakness with a mild fever of 100°.
The evening of January 7th, 2022 I had a gathering with my friends of about 6 people and only one other person tested positive. I was exposed to covid on January 7, 2022. I was notified on January 8th that a friend of mine had covid. January 9th I had post nasal drip and a scratchy throat. I also began to have body aches and night sweats. January 10th I went to urgent care to get a rapid covid test and it was negative. My symptoms got worse with a cough and continued body aches. January 11th it was the same. This morning I woke up with a very hoarse voice and a slight headache that I didn't have before. I have no fever and my oxygen saturation has always been in the upper 90s. I went back to the urgent care today and got tested again for covid which was positive. I just started a Z-Pak last night, and I took some vitamin D, zinc, and Claritin D.
felt like having COVID again after both doses; blood pressure is low and sometime plummets to about 70/40; nasal congestion; Muscle ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (felt like having COVID again after both doses), HYPOTENSION (blood pressure is low and sometime plummets to about 70/40), NASAL CONGESTION (nasal congestion), MYALGIA (Muscle ache) and HEADACHE (headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 045B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2020 and Pneumonia in October 2020. Concurrent medical conditions included Hypertension. Concomitant products included LOSARTAN for Blood pressure management, ZOLPIDEM TARTRATE (AMBIEN) for Sleep disorder NOS.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SUSPECTED COVID-19 (felt like having COVID again after both doses), HYPOTENSION (blood pressure is low and sometime plummets to about 70/40), NASAL CONGESTION (nasal congestion), MYALGIA (Muscle ache) and HEADACHE (headache). The patient was treated with CAFFEINE for Hypotension, at an unspecified dose and frequency. At the time of the report, SUSPECTED COVID-19 (felt like having COVID again after both doses), HYPOTENSION (blood pressure is low and sometime plummets to about 70/40) and NASAL CONGESTION (nasal congestion) outcome was unknown and MYALGIA (Muscle ache) and HEADACHE (headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Blood pressure measurement: 68/40 (Low) 68/40. On 26-May-2021, SARS-CoV-2 test: negative (Negative) Nasopharyngeal sample- negative. On 30-May-2021, SARS-CoV-2 test: negative (Negative) Nasopharyngeal sample- negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient also reported taking an unspecified pain medication and a muscle relaxer concomitantly. Patient stated that for SARS-CoV-2 infection got hospitalized on OCT 2.   This case was linked to MOD-2021-220941 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Jul-2021: Follow-up information contains  historical lab test data updated and historical COVID-19  related symptoms updated. On 08-Jul-2021: Follow up received on 08-JUL-2021 and contains No Significant INformation
Weakness; Fatigue; This spontaneous case was reported by a physician and describes the occurrence of ASTHENIA (Weakness) and FATIGUE (Fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness) and FATIGUE (Fatigue). At the time of the report, ASTHENIA (Weakness) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by reporter. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Jun-2021 and was forwarded to Moderna on 21-Jun-2021.    This spontaneous case was reported by a physician and describes the occurrence of ASTHENIA (Weakness) and FATIGUE (Fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness) and FATIGUE (Fatigue). At the time of the report, ASTHENIA (Weakness) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by reporter.
Deceased 12/4/2021; Hospitalized 11/26/2021; COVID-19 exposed unclear if test done; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: MD Primary Care Physician at Discharge: MD  Admission Date: 11/26/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute right MCA stroke [I63.511] Ischemic stroke [I63.9]   HOSPITAL COURSE Patient is a 67 yo male, history of PVD, HTN, CAD, cardiomyopathy, DM, CKD, tobacco use, and recent COVID exposure, who was admitted to Medical ICU from ED for concern of stroke in the presence of COVID pneumonia. Neuro ICU was consulted for stroke. To review, patient was found unresponsive on 11/26. He was last known well on the evening of 11/25. Down time is unknown. Patient has multiple family members at home who are COVID positive. Per ED report, patient was having some cough and respiratory symptoms while at home. EMS reportedly found patient unresponsive with a right sided gaze and left sided weakness. Patient was hypoxic with O2 sat in the 60's and a respiratory rate in the 40's. On arrival to outside ED, patients exam was documented as non verbal but following commands. Patient was stroke coded at 1130 on 11/26; initial NIH 32. Stat HCT was negative for hemorrhage. Due to unknown down time, patient was outside the window for TPA. CTA shows a left cervical ICA occlusion and a incompletely occlusive right cervical ICA thrombus. No intracranial occlusions reported. CTP showed a 7 ml core and 5 ml penumbra. Patient was showing some ST elevation in V1, V2 and lead 3 concerning for STEMI. He was given rectal aspirin. Per outside report, ED physician contacted both BW cardiology and stroke neurology for recommendations. Per cardiology, did not feel this was a STEMI, no acute need for heparin gtt from cardiac standpoint at this time. Stroke neurology recommended STAT MRI brain. There was no documented discussion regarding whether or not patient's candidacy for mechanical thrombectomy was discussed. It was assumed that patient was not a candidate. Patient was satting 90% on NRB. It was ultimately decided to admit to Medical ICU and patient was intubated for airway protection.    On 11/27an MRI brain was obtained and showed right MCA and watershed territory strokes, Left MCA/ACA watershed strokes, and possible small left petechial ICH. Throughout his ICU course his pulmonary status continued to decline and he developed severe ARDS, pneumonia, and pulmonary edema. Despite maximum medical efforts, including high dose sedation, paralytics, and prone positioning, the patient failed to make significant improvement from a pulmonary standpoint. Given his poor neurological exam in conjunction with his multiple bihemispheric strokes seen on brain MRI, as well as failure to improve on the ventilator, multiple family meetiings were held to discuss goals of care. It was decided that the current level of care and anticipated poor recovery did not align with the patients prior wishes. As such, the family elected to transition him to comfort measures. After all family was able to say their goodbyes, the patient was terminally extubated on 12/4/21. He passed away with family at his bedside at 3:53PM.
Fever highest of 101.5 degrees F.  Severe headache  Body aches  Mild diarrhea  Mild nausea  Chills/sweats  Arm pain (injection site)  Symptoms started early AM of 12/29/2020, fever broke early AM of 12/30/2020.
Dose administered after 30-day Use By Date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On 22-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter reported:  Date the vial was initially stored in the refrigerator: 16-Sep-2021. One dose of expired vaccine was administered on 22-Oct-2021 out of 108 doses.  No relevant concomitant medications were reported. No treatment information was provided.
He got the vaccine, had no issues with it other than being tired and lethargic for 2 days.  Then after 9 days the shoulder muscle was sore as if he had just gotten the vaccine.  He then had tingling, prickling sensations up and down his arm to his fingertips with occasional slight numbness.  He has not gone to his doctor, but it has not gotten any better.
Stroke; she had blood clots on her brain; headache; her left leg was numb like it was asleep; blurry vision; This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received second dose of bnt162b2 (BNT162B2, solution for injection, Lot Number: ER8736) in left arm via an unknown route of administration on 24Apr2021 at 10:10 (at the age 27-year-old) as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (BNT162B2, solution for injection, Lot Number: ER8727) right arm, via an unknown route of administration on 31Mar2021 as single dose for covid-19 immunization and experienced no adverse event. On 14May2021 at around 07:00 or 08:00, the patient experienced stroke. The patient was hospitalized for stroke from 15May2021 to May2021. On an unknown date, the patient had blood clots on her brain, headache, her left leg was numb like it was asleep, blurry vision. It was reported that patient was recently got her vision back to where she can stand the light long enough to do the research and call around. The stroke happened on 14May2021 and patient went to the hospital on 15May2021 for 5 days because she thought it was just a headache. The patient cannot find the exact date she was discharged. The vision was the first thing that went, then headache started. When patient woke up early in the morning her left leg was numb like it was asleep. Patient used the restroom and did her morning routine, and when she sat back down had the worst headache of her life. They said she had blood clots on her brain. When patient got there, they couldn't stop it because it had already happened and the damage was done. It was reported that patient knew she was going to be travelling and would start working around children. Patient was exposed to a lot of people and thought at the time it was the best thing to go ahead and get the vaccine to go back to a new normal. Patient had bloodwork test and drew so much blood trying to figure out how but results showed unknown. The most common stroke was a blood clot on the brain. Everything matches from the blurry vision to the headaches. Patient declines to report on any of the people she read about, she is just calling to report on herself. The stroke was early because her aunt had a stroke literally the week before and her wake was in the morning. She was getting ready for that. The patient had no other vaccinations within four weeks prior to the first administration date of the suspect vaccines. Patient's lab test included blood work: unknown on an unspecified date. The outcome of the events was unknown.  PSCC Communication was as provided contact information for Pfizer Legal Department and report reference number to the caller. Caller declined to complete reports on the people she read about online.  Information on Lot/Batch number was available. Additional Information has been requested.
After the vaccination about 7pm I noticed my HR elevating. In addition to that, I was having typical vaccine symptoms. Fatigue, fever. etc. heart elevated to 100 BPM and remained at the level consistently for 48-72 hours. All of the side effects resolved without treatment. Sent an message to doctor for concern, nurse called back and indicated symptoms were not a concern - no in-person visit.
Patient is not old enough to get Moderna and received Moderna vaccine.  Patient is feeling  normal, no any adverse side effect is occurred except little soreness in  arm with vaccination.
Pt complaint of swelling in arm (right) as well as pain. Cold compress and OTC pain meds did not help so I referred Pt to PCP.
sore shoulder for 3-5 days after previous doses; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (sore shoulder for 3-5 days after previous doses) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included RIVAROXABAN from 10-Apr-2022 to an unknown date for an unknown indication.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (sore shoulder for 3-5 days after previous doses). At the time of the report, ARTHRALGIA (sore shoulder for 3-5 days after previous doses) outcome was unknown.            Patient's height was reported as 5 foot 11 inches  No treatment details were reported. Patient started Rivaroxaban 15 mg twice daily for 30 days and will take 20 mg for another 30 days and re-evaluated. It was reported that patient had Sore shoulders for 3-5 days, after Moderna shots .   This case was linked to MOD-2022-542545 (Patient Link).
zoster related Guillain-Barre syndrome; zoster related Guillain-Barre syndrome; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient (pt) of unknown age and gender. No information regarding the pt's pertinent medical history, drug reactions or allergies, and concomitant medications was provided. On or about 18-SEP-2012, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, dose number, route of administration, anatomical site of vaccination, lot number and expiration date were not provided), as prescribed and/or administered by a healthcare provider at a public clinic, for the long-term prevention of shingles and/or zoster-related conditions.At the time of the pt's vaccination, the pt relied on the warning label affixed to the zoster vaccine live (ZOSTAVAX), and the information relayed through the pt's healthcare providers that the zoster vaccine live (ZOSTAVAX) was effective in preventing shingles on a permanent basis and did not carry any significant risk of adverse effects, which induced the pt to be vaccinated. On an unknown date, reported as subsequent to the pt's zoster vaccine live (ZOSTAVAX) inoculation, the pt was treated by a physician for zoster related Guillain-Barre syndrome. As a direct and proximate result of the pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, the pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies;diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future.The outcomes of the events were considered as not recovered. The reporter assessed that the events were related to the zoster vaccine live (ZOSTAVAX).  Upon internal review, the event of zoster related Guillain-Barre syndrome was considered to be medically significant.
Child given MMRV and Varicella. Medical Assistant that administered immunizations thought she was giving MMR and Varicella separate. Child got two doses of Varicella.